In order to regenerate myocardial tissues with functional characteristics, we need to copy some properties of the myocardium, such as its extracellular matrix and electrical conductivity. In this study, we synthesized nanosheets of Molybdenum disulfide (MoS2), and integrated them into polycaprolactone (PCL) and electrospun on the surface of decellularized human amniotic membrane (DHAM) with the purpose of improving the scaffolds mechanical properties and electrical conductivity. For in vitro studies, we seeded the mouse embryonic cardiac cells, mouse Embryonic Cardiac Cells (mECCs), on the scaffolds and then studied the MoS2 nanocomposites by scanning electron microscopy and Raman spectroscopy. In addition, we characterized the DHAM/PCL and DHAM/PCL-MoS2 by SEM, transmission electron microscopy, water contact angle measurement, electrical conductivity, and tensile test. Besides, we confirmed the scaffolds are biocompatible by 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, MTT assay. Furthermore, by means of SEM images, it was shown that mECCs attached to the DHAM/PCL-MoS2 scaffold have more cell aggregations and elongated morphology. Furthermore, through the Real-Time PCR and immunostaining studies, we found out cardiac genes were maturated and upregulated, and they also included GATA-4, c-TnT, NKX 2.5, and alpha-myosin heavy chain in cells cultured on DHAM/PCL-MoS2 scaffold in comparison to DHAM/PCL and DHAM. Therefore, in terms of cardiac tissue engineering, DHAM nanofibrous scaffolds reinforced by PCL-MoS2 can be suggested as a proper candidate.
ViraniSSAlonsoABenjaminEJ, et al.Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation2020; 141: E139–E596.
2.
JarrellDKVandersliceEJVeDepoMC, et al.Engineering myocardium for heart regeneration-advancements, considerations, and future directions. Front Cardiovasc Med2020; 7: 586261.
HirtMNHansenAEschenhagenT. Cardiac tissue engineering: state of the art. Circ Research2014; 114(2): 354–367.
5.
SegersVFMLeeRT. Stem-cell therapy for cardiac disease. Nature2008; 451(7181): 937–942.
6.
MirahmadiMAhmadiankiaNNaderi-MeshkinH, et al.Hypoxia and laser enhance expression of SDF-1 in muscles cells. Cell Molecular Biology (Noisy-le-Grand)2016; 62(5): 31–37.
7.
DongRMaPXGuoB. Conductive biomaterials for muscle tissue engineering. Biomaterials2020; 229: 119584.
8.
DussoyerMMichopoulouARousselleP. Decellularized scaffolds for skin repair and regeneration. Appl Sci2020; 10(10): 3435.
9.
GuoXKaplunovskyAZakaR, et al.Modulation of cell attachment, proliferation, and angiogenesis by decellularized, dehydrated human amniotic membrane in in vitro models. Wounds2017; 29(1): 28–38.
10.
Sous NaasaniLIDamo SouzaAFRodriguesC, et al.Decellularized human amniotic membrane associated with adipose derived mesenchymal stromal cells as a bioscaffold: physical, histological and molecular analysis. Biochem Eng J2019; 152: 107366.
11.
FouadHSabryDElsetohyK, et al.Therapeutic efficacy of amniotic membrane stem cells and adipose tissue stem cells in rats with chemically induced ovarian failure. J Advanced Research2016; 7(2): 233–241.
12.
ZhouZLongDHsuC-C, et al.Nanofiber-reinforced decellularized amniotic membrane improves limbal stem cell transplantation in a rabbit model of corneal epithelial defect. Acta Biomat2019; 97: 310–320.
13.
Villamil BallesterosACSegura PuelloHRLopez-GarciaJA, et al.Bovine decellularized amniotic membrane: extracellular matrix as scaffold for mammalian skin. Polymers2020; 12(3): 590.
14.
KakabadzeZChakhunashviliDGogilashviliK, et al.Bone marrow stem cell and decellularized human amniotic membrane for the treatment of nonhealing wound after radiation therapy. Exp Clin Transplant2019; 17(Suppl 1): 92–98.
15.
CuiHChaiYYuY. Progress in developing decellularized bioscaffolds for enhancing skin construction. J Biomed Mat Res A2019; 107(8): 1849–1859.
16.
FranciscoJCorrea CunhaRCardosoMA, et al.Decellularized amniotic membrane scaffold as a pericardial substitute: an in vivo study. Transplant Proc. 2016; 48(8): 2845–2849.
17.
RoyRHaaseTMaN, et al.Decellularized amniotic membrane attenuates postinfarct left ventricular remodeling. J Surg Res2016; 200(2): 409–419.
18.
BrennanJAArrizabalagaJHNollertMU. Development of a small diameter vascular graft using the human amniotic membrane. Cardiovasc Eng Technology2014; 5(1): 96–109.
19.
MilanPBAminiNJoghataeiMT, et al.Decellularized human amniotic membrane: from animal models to clinical trials. Methods2020; 171: 11–19.
20.
BeckerMMaringJSchneiderM, et al.Towards a novel patch material for cardiac applications: tissue-specific extracellular matrix introduces essential key features to decellularized amniotic membrane. Int Journal Mol Sci2018; 19(4): 1032.
21.
KhorramirouzRKameliSMFendereskiK, et al.Evaluating the efficacy of tissue-engineered human amniotic membrane in the treatment of myocardial infarction. Regen Med2019; 14(2): 113–126.
22.
HenryJJDDelrosarioLFangJ, et al.Development of injectable amniotic membrane matrix for postmyocardial infarction tissue repair. Adv Healthc Mater2020; 9(2): 1900544.
23.
CattoVFarèSCattaneoI, et al.Small diameter electrospun silk fibroin vascular grafts: mechanical properties, in vitro biodegradability, and in vivo biocompatibility. Mater Sci Eng C2015; 54: 101–111.
24.
YaoQCosmeJGLXuT, et al.Three dimensional electrospun PCL/PLA blend nanofibrous scaffolds with significantly improved stem cells osteogenic differentiation and cranial bone formation. Biomaterials2017; 115: 115–127.
25.
KaiDPrabhakaranMPJinG, et al.Potential of VEGF-encapsulated electrospun nanofibers for in vitro cardiomyogenic differentiation of human mesenchymal stem cells. J Tissue Eng Regen Med2017; 11(4): 1002–1010.
26.
HosseinzadehSNazariHSadegzadehN, et al.Polyethylenimine: a new differentiation factor to endothelial/cardiac tissue. J Cell Biochem2019; 120(2): 1511–1521.
27.
GhorbaniSEyniHBazazSR, et al.Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics. Polym Sci Ser A2018; 60(6): 707–722.
28.
KitsaraMAgbulutOKontziampasisD, et al.Fibers for hearts: a critical review on electrospinning for cardiac tissue engineering. Acta Biomat2017; 48: 20–40.
29.
JoannePKitsaraMBoitardS-E, et al.Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy. Biomaterials2016; 80: 157–168.
30.
RameshBCherianKMFakoyaAOJ. Fabrication and electrospinning of 3D biodegradable poly-l-lactic acid (PLLA) nanofibers for clinical application. Methods Mol Biol2020; 2125: 119–128.
31.
LeeKKimH-YLotyaM, et al.Electrical characteristics of molybdenum disulfide flakes produced by liquid exfoliation. Adv Mat2011; 23(36): 4178–4182.
32.
TeoWZChngELKSoferZ, et al.Cytotoxicity of exfoliated transition-metal dichalcogenides (MoS2, WS2, and WSe2) is lower than that of graphene and its analogues. Chemistry2014; 20(31): 9627–9632.
33.
YinWYanLYuJ, et al.High-throughput synthesis of single-layer MoS2 nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy. ACS Nano2014; 8(7): 6922–6933.
34.
LiuTWangCGuX, et al.Drug delivery with PEGylated MoS2Nano-sheets for combined photothermal and chemotherapy of cancer. Adv Mater2014; 26(21): 3433–3440.
35.
LiBLSetyawatiMIChenL, et al.Directing assembly and disassembly of 2D MoS2 nanosheets with DNA for drug delivery. ACS Appl Mater Inter2017; 9(18): 15286–15296.
36.
KimJKimHKimWJ. Single-layered MoS2 -PEI-PEG nanocomposite-mediated gene delivery controlled by photo and redox stimuli. Small2016; 12(9): 1184–1192.
37.
WangSLiKChenY, et al.Biocompatible PEGylated MoS2 nanosheets: controllable bottom-up synthesis and highly efficient photothermal regression of tumor. Biomaterials2015; 39: 206–217.
ZhangXNieJYangX, et al.Nanostructured molybdenum disulfide biointerface for adhesion and osteogenic differentiation of mesenchymal stem cells. Appl Mater Today2018; 10: 164–172.
40.
WangSQiuJGuoW, et al.A nanostructured molybdenum disulfide film for promoting neural stem cell neuronal differentiation: toward a nerve tissue-engineered 3D scaffold. Adv Biosyst2017; 1(5): 1600042.
41.
NazariHHeirani‐TabasiAAlavijehMS, et al.Nanofibrous composites reinforced by MoS 2 nanosheets as a conductive scaffold for cardiac tissue engineering. ChemistrySelect2019; 4(39): 11557–11563.
42.
NazariHHeirani‐TabasiAHajiabbasM, et al.Incorporation of two‐dimensional nanomaterials into silk fibroin nanofibers for cardiac tissue engineering. Polym Adv Tech2020; 31(2): 248–259.
43.
VakilianSNorouziMSoufi-ZomorrodM, et al.L. inermis -loaded nanofibrous scaffolds for wound dressing applications. Tissue Cell2018; 51: 32–38.
44.
HosseinzadehSZareiZEsna-ashariS, et al.Cell interactions under controlled of surface substrate. J Appl Tissue Eng2017; 3(1): 10–28.
45.
AshtariKNazariHKoH, et al.Electrically conductive nanomaterials for cardiac tissue engineering. Adv Drug Deliv Rev2019; 144: 162–179.
46.
WangSChenYLiX, et al.Injectable 2D MoS2-Integrated drug delivering implant for highly efficient NIR-triggered synergistic tumor hyperthermia. Adv Mater2015; 27(44): 7117–7122.
47.
ShenSChaoYDongZ, et al.Bottom-up preparation of uniform ultrathin rhenium disulfide nanosheets for image-guided photothermal radiotherapy. Adv Funct Mater2017; 27(28): 1700250.
48.
QianXShenSLiuT, et al.Two-dimensional TiS2 nanosheets for in vivo photoacoustic imaging and photothermal cancer therapy. Nanoscale2015; 7(14): 6380–6387.
49.
HosseinzadehSMahmoudifardMMohamadyar-ToupkanlouF, et al.The nanofibrous PAN-PANi scaffold as an efficient substrate for skeletal muscle differentiation using satellite cells. Bioproc Biosyst Eng2016; 39(7): 1163–1172.
50.
DadgarNGhiaseddinAIraniS, et al.Bioartificial injectable cartilage implants from demineralized bone matrix/PVA and related studies in rabbit animal model. J Biomater Appl2021; 35(10): 1315–1326.
51.
HosseinzadehSSoleimaniMRezayatSM, et al.The activation of satellite cells by nanofibrous poly ɛ-caprolacton constructs. J Biomat Appl2014; 28(6): 801–812.
52.
DadgarNGhiaseddinAIraniS, et al.Cartilage tissue engineering using injectable functionalized Demineralized Bone Matrix scaffold with glucosamine in PVA carrier, cultured in microbioreactor prior to study in rabbit model. Mater Sci Eng C2021; 120: 111677.
53.
ChenLChenFTronganhN, et al.MoS2/graphene nanocomposite with enlarged interlayer distance as a high performance anode material for lithium-ion battery. J Mater Res2016; 31(20): 3151–3160.
54.
ZhangCWangZBhoyateS, et al.MoS2 decorated carbon nanofibers as efficient and durable electrocatalyst for hydrogen evolution reaction. C2017; 3(4): 33.
Ling-LingEZhaoYSGuoXM, et al.Enrichment of cardiomyocytes derived from mouse embryonic stem cells. J Heart Lung Transplant2006; 25(6): 664–674.
57.
SepulvedaJLBelaguliNNigamV, et al.GATA-4 and Nkx-2.5 coactivate Nkx-2 DNA binding targets: role for regulating early cardiac gene expression. Mol Cell Biol1998; 18(6): 3405–3415.
58.
MorkinE. Control of cardiac myosin heavy chain gene expression. Microsc Res Tech2000; 50(6): 522–531.
59.
Mohammadi NasrSRabieeNHajebiS, et al.Biodegradable nanopolymers in cardiac tissue engineering: from concept towards nanomedicine. Int J Nanomed2020; 15: 4205–4224.
60.
HasmadHYusofMRMohd RaziZR, et al.Human amniotic membrane with aligned electrospun fiber as scaffold for aligned tissue regeneration. Tissue Eng C Methods2018; 24(6): 368–378.
61.
TangYYangJYinL, et al.Fabrication of superhydrophobic polyurethane/MoS2 nanocomposite coatings with wear-resistance. Colloids Surf A Physicochem Eng Asp2014; 459: 261–266.
62.
YeHZhaoMLiM, et al.Influences of ambient temperature, charge density on wettability properties of monolayer MoS 2 films. In: Nano/Micro Engineered and Molecular Systems (NEMS) 2017 IEEE 12th International Conference; 2017.
63.
ShuaiCSunHGaoC, et al.Mechanical reinforcement of bioceramics scaffolds via fracture energy dissipation induced by sliding action of MoS2 nanoplatelets. J Mech Behav Biomed Mater2017; 75: 423–433.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
